The MEK/ERK map kinase pathway in antipsychotic actions

被引：0

作者：

Browning, JL ^{[1
]}

Young, KA ^{[1
]}

Hicks, PB ^{[1
]}

机构：

[1] Scott & White Mem Hosp & Clin, Neuropsychiat Res Program, Temple, TX 76508 USA

来源：

SCHIZOPHRENIA BULLETIN | 2005年 / 31卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：296 / 296

页数：1

共 50 条

[41] Coupling of endothelin receptors to the ERK/MAP kinase pathway -: Roles of palmitoylation and Gαq [J].

Cramer, H ;

Schmenger, K ;

Heinrich, K ;

Horstmeyer, A ;

Böning, H ;

Breit, A ;

Piiper, A ;

Lundstrom, K ;

Müller-Esterl, W ;

Schroeder, C .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (20) :5449-5459

[42] EFFECT OF PHOSPHODIESTERASE INHIBITORS ON ERK1/2 MAP KINASE SIGNALING PATHWAY [J].

Markova, Tz. ;

Aragane, Y. ;

Tabuchi, M. ;

Alexieva, B. ;

Nikolova, E. ;

Higashino, H. .

PHARMACIA, 2010, 57 (1-4) :30-34

[43] FUNCTIONAL DIVERGENCE OF THE MAP KINASE PATHWAY - ERK1 AND ERK2 ACTIVATE SPECIFIC TRANSCRIPTION FACTORS [J].

CHUANG, CF ;

NG, SY .

FEBS LETTERS, 1994, 346 (2-3) :229-234

[44] A DIVERGENCE IN THE MAP KINASE REGULATORY NETWORK DEFINED BY MEK KINASE AND RAF [J].

LANGECARTER, CA ;

PLEIMAN, CM ;

GARDNER, AM ;

BLUMER, KJ ;

JOHNSON, GL .

SCIENCE, 1993, 260 (5106) :315-319

[45] Effective targeting of MEK (MAP kinase, kinase) in breast cancer cells [J].

Gan, G. ;

Roberts, N. ;

Lopez-Davila, V. ;

Loizidou, M. ;

Welch, H. .

BRITISH JOURNAL OF SURGERY, 2013, 100 :12-12

[46] MAP kinase/ERK kinase 1 (MEK1) phosphorylates regulator of calcineurin 1 (RCAN1) to regulate neuronal differentiation [J].

Kim, Seon Sook ;

Lee, Eun Hye ;

Shin, Jin Hak ;

Seo, Su Ryeon .

JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (02) :1406-1417

[47] Pharmacologic inhibitors of the MEK-MAP kinase pathway are associated with toxicity to the skin, stomach, intestines, and liver [J].

Brown, Alan P. ;

Reindel, James F. ;

Grantham, Lonnie ;

Loi, Cho-Ming ;

Van Becelaere, Keri ;

Leopold, Judy ;

Graziano, Michael J. .

CANCER RESEARCH, 2006, 66 (08)

[48] Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway [J].

Takeishi, Kazuki ;

Taketomi, Akinobu ;

Shirabe, Ken ;

Toshima, Takeo ;

Motomura, Takashi ;

Ikegami, Toru ;

Yoshizumi, Tomoharu ;

Sakane, Fumio ;

Maehara, Yoshihiko .

JOURNAL OF HEPATOLOGY, 2012, 57 (01) :77-83

[49] Protein kinase C delta activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf [J].

Ueda, Y ;

Hirai, S ;

Osada, S ;

Suzuki, A ;

Mizuno, K ;

Ohno, S .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (38) :23512-23519

[50] Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway [J].

Mody, N ;

Leitch, J ;

Armstrong, C ;

Dixon, J ;

Cohen, P .

FEBS LETTERS, 2001, 502 (1-2) :21-24

← 1 2 3 4 5 →